分化型甲状腺癌:ATA淋巴结风险因素在N1b患者中的作用
该回顾性研究分析了347例接受侧颈淋巴结清扫的N1b分化型甲状腺癌患者,评估ATA风险分层中的淋巴结因素对生存的影响。多因素分析显示阳性淋巴结数目和淋巴结转移灶大小分别是局部区域控制和无转移生存的独立风险因素。
核心结论
- 在N1b分化型甲状腺癌患者中,阳性淋巴结数目和淋巴结转移灶大小分别是局部区域复发和远处转移的独立风险因素。
研究设计与样本
- 回顾性研究,纳入347例接受治疗性侧颈淋巴结清扫的N1b分化型甲状腺癌患者,共实施401次侧颈淋巴结清扫。
主要发现
- 平均阳性淋巴结数目为9枚,平均淋巴结比率为0.27,平均转移灶直径为15.5 mm。
- 结外扩展发生率为25.9%(微观结外扩展22.5%,宏观结外扩展3.5%)。
临床怎么用
- 对于N1b分化型甲状腺癌患者,应关注阳性淋巴结数目和转移淋巴结大小以评估局部区域复发和远处转移风险。
局限性
- 回顾性研究设计,证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Nodal involvement is frequent in patients with differentiated thyroid cancers (DTCs), but its prognostic relevance is not univocal. Some characteristics of nodal metastases can increase the risk of recurrence. We attempted to quantify the impact on survival of nodal factors included in the American Thyroid Association (ATA) risk stratification system in N1b patients with DTC. STUDY DESIGN: Retrospective study. METHODS: A retrospective analysis of patients affected by DTC who underwent therapeutic lateral neck dissection (ND) was performed. The impact on the prognosis of the number of positive lymph nodes (LNs), dimension of nodal metastasis, and microscopic and macroscopic extranodal extension (miENE and maENE, respectively) was investigated. RESULTS: The study included 347 N1b patients who underwent 401 therapeutic lateral NDs. Mean number of positive LNs was nine, mean nodal ratio was 0.27, and mean diameter of metastasis was 15.5 mm. ENE was detected in 25.9% of patients (22.5% miENE and 3.5% maENE). In univariate analysis, the presence of maENE had an impact on disease specific survival (DSS) (P = .023); increasing number of positive LNs affected DSS and locoregional control (LRC) (P = .009 and =.006, respectively); increasing metastatic node dimension was a risk factors for overall survival, DSS, and metastases free survival (MFS) (P = .05, =.013 and =.016). In multivariate analysis, number of positive LNs and LN dimension were independent risk factors for LRC and MFS, respectively (HR 1.1, P = .028; HR 1.1, P = .026). CONCLUSIONS: In our analysis on a cohort of N1b patients, the number of positive LNs and LN dimension were confirmed as independent risk factors for locoregional and distant recurrence, respectively. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E1029-E1034, 2021.
引用
- Taboni S, Paderno A, Giordano D, et al. Differentiated Thyroid Cancer: The Role of ATA Nodal Risk Factors in N1b Patients. Laryngoscope. 2020. PMID: 33319385. doi:10.1002/lary.29057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。